Showing results (21-30 of 12,155) with videos related to
Sort By:
Pageof 1,216
Bioorganic & Medicinal Chemistry Letters|August 16, 2005
Potent and orally active non-peptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexylpiperazinesFabio C Tucci, Nicole S White, Stacy Markison, et al.Journal of Medicinal Chemistry|July 23, 2004
Phenylguanidines as selective nonpeptide melanocortin-5 receptor antagonistsChen Chen, Jinghua Yu, Beth A Fleck, et al.Current Opinion in Pharmacology|December 27, 2005
Glutamate- and GABA-based CNS therapeuticsAlan C Foster, John A KempCancers|May 19, 2019
Pretreatment Cancer-Related Cognitive Impairment-Mechanisms and OutlookBrennan Olson, Daniel L. MarksCurrent Opinion in Clinical Nutrition and Metabolic Care|April 20, 2011
Hypothalamic regulation of muscle metabolismTheodore P Braun, Daniel L MarksExpert Opinion on Investigational Drugs|September 28, 2005
The use of melanocortin antagonists in cachexia of chronic diseaseJarrad M Scarlett, Daniel L MarksCurrent Opinion in Supportive and Palliative Care|August 25, 2010
Neuropeptides in the pathophysiology and treatment of cachexiaStephanie M Krasnow, Daniel L MarksNature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Therapy insight: Use of melanocortin antagonists in the treatment of cachexia in chronic diseaseMark D DeBoer, Daniel L MarksJournal of the Optical Society of America. A, Optics, Image Science, and Vision|January 13, 2018
Mode diversity of weakly modulated cavity antennasDaniel L Marks, David R SmithFrontiers in Physiology|February 19, 2015
The regulation of muscle mass by endogenous glucocorticoidsTheodore P Braun, Daniel L MarksPageof 1,216